C. Fermon

634 total citations
16 papers, 441 citations indexed

About

C. Fermon is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, C. Fermon has authored 16 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 6 papers in Genetics. Recurrent topics in C. Fermon's work include Diabetes Management and Research (7 papers), Diabetes and associated disorders (6 papers) and Pancreatic function and diabetes (4 papers). C. Fermon is often cited by papers focused on Diabetes Management and Research (7 papers), Diabetes and associated disorders (6 papers) and Pancreatic function and diabetes (4 papers). C. Fermon collaborates with scholars based in France, United States and Switzerland. C. Fermon's co-authors include Marie‐Christine Vantyghem, Chantal Mathieu, Colin Dayan, Peter Diem, J. B. L. Hoekstra, Anders Frid, Jeroen Hermanides, Kirsten Nørgaard, I. M. E. Wentholt and J. Hans DeVries and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Transplantation and Clinical Endocrinology.

In The Last Decade

C. Fermon

15 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Fermon France 10 296 192 189 88 30 16 441
W. Y. Ng Singapore 11 137 0.5× 146 0.8× 89 0.5× 56 0.6× 16 0.5× 18 321
M Borkenstein Austria 10 206 0.7× 261 1.4× 160 0.8× 38 0.4× 28 0.9× 21 436
S. Soskin France 8 214 0.7× 224 1.2× 141 0.7× 150 1.7× 20 0.7× 12 408
P Sawtell United Kingdom 5 465 1.6× 417 2.2× 273 1.4× 35 0.4× 59 2.0× 6 567
Georgia Kassi Greece 11 248 0.8× 130 0.7× 165 0.9× 46 0.5× 42 1.4× 27 436
Marco Capizzi Italy 11 498 1.7× 598 3.1× 420 2.2× 111 1.3× 56 1.9× 14 749
Mika Martiskainen Finland 10 63 0.2× 129 0.7× 77 0.4× 60 0.7× 37 1.2× 22 365
Eduarda Pizarro Spain 13 218 0.7× 63 0.3× 97 0.5× 26 0.3× 8 0.3× 24 386
Francesca Di Candia Italy 10 155 0.5× 123 0.6× 111 0.6× 31 0.4× 29 1.0× 27 256
H. Kromann Denmark 13 434 1.5× 559 2.9× 373 2.0× 75 0.9× 40 1.3× 27 737

Countries citing papers authored by C. Fermon

Since Specialization
Citations

This map shows the geographic impact of C. Fermon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Fermon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Fermon more than expected).

Fields of papers citing papers by C. Fermon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Fermon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Fermon. The network helps show where C. Fermon may publish in the future.

Co-authorship network of co-authors of C. Fermon

This figure shows the co-authorship network connecting the top 25 collaborators of C. Fermon. A scholar is included among the top collaborators of C. Fermon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Fermon. C. Fermon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Floch, Jean‐Pierre Le, Catherine Petit, Alfred Penfornis, et al.. (2017). An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France. Diabetes Technology & Therapeutics. 19(11). 623–632. 35 indexed citations
2.
Hermanides, Jeroen, Kirsten Nørgaard, Daniela Bruttomesso, et al.. (2011). Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabetic Medicine. 28(10). 1158–1167. 131 indexed citations
3.
Schaepelynck, Pauline, Éric Renard, N. Jeandidier, et al.. (2011). A Recent Survey Confirms the Efficacy and the Safety of Implanted Insulin Pumps During Long-Term Use in Poorly Controlled Type 1 Diabetes Patients. Diabetes Technology & Therapeutics. 13(6). 657–660. 21 indexed citations
4.
Vantyghem, Marie‐Christine, Chris Vercruysse, C. Fermon, et al.. (2010). PO36 Les inhibiteurs de mTOR ont-ils un rôle spécifique en thérapie cellulaire du diabète ?. Diabetes & Metabolism. 36. A37–A37.
5.
Hermanides, Jeroen, Kirsten Nørgaard, Daniela Bruttomesso, et al.. (2009). Sensor augmented pump therapy substantially lowers HbA(1c); a randomized controlled trial. Lund University Publications (Lund University). 6 indexed citations
6.
Vantyghem, Marie‐Christine, C. Fermon, Alain Duhamel, et al.. (2009). Intraperitoneal Insulin Infusion Versus Islet Transplantation: Comparative Study in Patients with Type 1 Diabetes. Transplantation. 87(1). 66–71. 26 indexed citations
7.
Fontaine, P., Philippe Deruelle, C. Fermon, & A. Vambergue. (2009). P179 Variations de l’hématocrite au cours de la grossesse chez les femmes diabétiques : conséquences sur l’auto surveillance glycémique capillaire. Diabetes & Metabolism. 35. A70–A70. 2 indexed citations
8.
Vantyghem, Marie‐Christine, Jacqueline Capeau, C. Fermon, et al.. (2008). Fertility and Obstetrical Complications in Women withLMNA-Related Familial Partial Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism. 93(6). 2223–2229. 69 indexed citations
9.
Vantyghem, Marie‐Christine, C. Fermon, Corinne Vigouroux, et al.. (2007). Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Clinical Endocrinology. 67(2). 247–249. 15 indexed citations
10.
11.
Vantyghem, Marie‐Christine, et al.. (2005). Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients. Diabetes & Metabolism. 31(5). 496–498. 16 indexed citations
12.
Guerci, Bruno, Nadia Tubiana‐Rufi, B. Bauduceau, et al.. (2005). Advantages to using capillary blood ɛ-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes & Metabolism. 31(4). 401–406. 56 indexed citations
13.
Soudan, Benoı̂t, et al.. (2003). Extreme subcutaneous insulin resistance: a misunderstood syndrome. Diabetes & Metabolism. 29(5). 539–546. 21 indexed citations
14.
Fermon, C.. (2003). Data management aujourd’hui dans l’autosurveillance des patients diabétiques. Diabetes & Metabolism. 29(2). 2S31–2S36. 1 indexed citations
15.
Vambergue, A., Lucia Rugeri, Patrick Devos, et al.. (2001). Factor VII, Tissue Factor Pathway Inhibitor, and Monocyte Tissue Factor in Diabetes Mellitus: Influence of Type of Diabetes, Obesity Index, and Age. Thrombosis Research. 101(5). 367–375. 32 indexed citations
16.
Fossati, P, Didier Dewailly, J Buvat, et al.. (1985). Medical Treatment of Hyperprolactinemia. Hormone Research. 22(3). 228–238. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Y. Ng Breakdown of academic impact, for papers by M Borkenstein Breakdown of academic impact, for papers by S. Soskin Breakdown of academic impact, for papers by P Sawtell Breakdown of academic impact, for papers by Georgia Kassi Breakdown of academic impact, for papers by Marco Capizzi Breakdown of academic impact, for papers by Mika Martiskainen Breakdown of academic impact, for papers by Eduarda Pizarro Breakdown of academic impact, for papers by Francesca Di Candia Breakdown of academic impact, for papers by H. Kromann
Rankless by CCL
2026